A randomized, double-blind, placebo-controlled trial for Xinguan Fuzheng Zhuanyin Decoction to reduce the viral load of the delta variant of COVID-19
Phase 1
Recruiting
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2100004966
- Lead Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Meet the diagnostic criteria for COVID-19 (National Eighth Edition);
2. Aged over 18 years;
3. Normal body temperature within 48 hours;
4. In the case of inhaling air, SpO2 > 93%;
5. The onset time is more than 7 days;
6. Sign informed consent.
Exclusion Criteria
1. The nucleic acid test turns negative twice in a row (24 hours apart);
2. Those who meet the discharge criteria and have a positive nucleic acid after discharge;
3. Severely and critically ill patients (8th edition standard);
4. Abnormal liver and kidney function (more than 2 times the normal value);
5. Allergic to known traditional Chinese medicine;
6. Those who do not cooperate with taking traditional Chinese medicine;
7. Pregnant women.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of viral load;Prognosis;
- Secondary Outcome Measures
Name Time Method CT imaging changes of chest;The ratio of nucleic acid to negative;The change of tongue and pulse ;Nucleic acid negative time;Major symptoms disappeared;Hospital stays;